Laurain, A., Metivier, S., Haour, G., Larrey, D., Dorival, C., Hezode, C., . . . group, o. b. o. t. A. H. s. (2019). Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort. BMC.
Chicago Style (17th ed.) CitationLaurain, Anne, et al. Safety and Efficacy of the Combination Simeprevir-sofosbuvir in HCV Genotype 1- and 4-mono-infected Patients from the French ANRS CO22 Hepather Cohort. BMC, 2019.
MLA (9th ed.) CitationLaurain, Anne, et al. Safety and Efficacy of the Combination Simeprevir-sofosbuvir in HCV Genotype 1- and 4-mono-infected Patients from the French ANRS CO22 Hepather Cohort. BMC, 2019.
Warning: These citations may not always be 100% accurate.